| Literature DB >> 10607891 |
A Rizzi1, R Bigoni, G Caló, R Guerrini, S Salvadori, D Regoli.
Abstract
Nociceptin, nociceptin-(1-13)-NH(2), Ac-RYYRWK-NH(2), [Phe(1)psi(CH(2)&z.sbnd;NH)Gly(2)]nociceptin-(1-13)-NH(2), the new nociceptin analog [Nphe(1)]nociceptin-(1-13)-NH(2), and endomorphin-1 have been tested in the isolated mouse colon. All peptides, except [Nphe(1)]nociceptin-(1-13)-NH(2), caused concentration-dependent, tetrodotoxin-sensitive contractions showing similar maximal effects. Naloxone (1 microM) blocked the effect of endomorphin-1 but not that of the other peptides. [Nphe(1)]nociceptin-(1-13)-NH(2) (10 microM) was inactive against endomorphin-1, but antagonized the contractile effects of nociceptin receptor ligands showing similar pA(2) values (approximately 6.0). The present findings indicate that [Nphe(1)]nociceptin-(1-13)-NH(2) is a low-potency, selective nociceptin receptor antagonist, devoid of residual agonist activity.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10607891 DOI: 10.1016/s0014-2999(99)00730-x
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432